KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Raw Materials: 2011-2019

Historic Raw Materials for Emergent BioSolutions (EBS) over the last 9 years, with Dec 2019 value amounting to $70.5 million.

  • Emergent BioSolutions' Raw Materials was N/A to $77.7 million in Q1 2020 from the same period last year, while for Mar 2020 it was $77.7 million, marking a year-over-year change of. This contributed to the annual value of $70.5 million for FY2019, which is 36.10% up from last year.
  • Per Emergent BioSolutions' latest filing, its Raw Materials stood at $70.5 million for FY2019, which was up 36.10% from $51.8 million recorded in FY2018.
  • In the past 5 years, Emergent BioSolutions' Raw Materials registered a high of $70.5 million during FY2019, and its lowest value of $21.3 million during FY2015.
  • Its 3-year average for Raw Materials is $52.8 million, with a median of $51.8 million in 2018.
  • Data for Emergent BioSolutions' Raw Materials shows a peak YoY soared of 44.24% (in 2016) over the last 5 years.
  • Emergent BioSolutions' Raw Materials (Yearly) stood at $21.3 million in 2015, then skyrocketed by 44.24% to $30.7 million in 2016, then grew by 17.64% to $36.1 million in 2017, then skyrocketed by 43.49% to $51.8 million in 2018, then surged by 36.10% to $70.5 million in 2019.